Outcome of Patients Receiving Venetoclax for Chronic Lymphocytic Leukemia (CLL) in Real-Life Clinical Practice: Results of the French ATU Program on Behalf of the Filo Group

Florian Bouclet, Romain Guièze, Marie‐Sarah Dilhuydy et al.|Blood|2018

Cited by 1